LIPID PEROKSIDLANISHINING KIMYOVIY MEXANIZMLARI VA YURAK-QON TOMIR KASALLIKLARIDAGI AHAMIYATI

Shaismatova G. X., Xodjimurodov D. I., Pardayev S. M. & Ikromova S. R.


Annotatsiya

Mazkur maqolada lipid peroksidlanishining kimyoviy mexanizmlari, hujayra membranalariga va biomolekulalarga ta’siri, shuningdek, yurak-qon tomir kasalliklaridagi roli o‘rganildi. maqolada lipid peroksidlanish jarayonini oldini olish va davolash bo‘yicha yondashuvlar ham tahlil qilindi.


Adabiyotlar

  1. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
  2. Madam A., Smith J., et al. Oxidized LDL and atherosclerosis: Molecular mechanisms. Cardiovasc Res. 2015;107:242–254.
  3. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 4th Edition. Oxford University Press, 2006.
  4. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2017;4:180–183.
  5. 5.Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2002;43:213–228.
  6. Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4:118–126.
  7. Madam A., et al. Lipid peroxidation in cardiovascular diseases: Clinical implications. Clin Chim Acta. 2016;456:52–60.
  8. Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655–673.
  9. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707–727.
  10. Madam B., et al. Antioxidant therapy in cardiovascular disease: Current evidence. Curr Opin Lipidol. 2013;24:356–362.